Hart v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
| Gary Hart |
| Sanofi US Services Inc., GlaxoSmithKline, LLC, Pfizer, Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. |
| 3:2019cv02296 |
| December 2, 2019 |
| US District Court for the Southern District of California |
| Mitchell D Dembin |
| Thomas J Whelan |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 pl |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 7, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Summons Issued. Counsel receiving this notice electronically should print this summons and serve it in accordance with Rule 4, Fed.R.Civ.P and LR 4.1. (sxa) |
| Filing 1 COMPLAINT with Jury Demand against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services Inc. ( Filing fee $ 400 receipt number 0974-13220928.), filed by Gary Hart. (Attachments: #1 Civil Cover Sheet)The new case number is 3:19-cv-02296-W-MDD. Judge Thomas J. Whelan and Magistrate Judge Mitchell D. Dembin are assigned to the case. (Moore, Jennifer)(sxa) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
